JP Morgan Chase
CLMT icon

JP Morgan Chase’s Calumet Specialty Products CLMT Stock Holding History

JP Morgan Chase’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,000
Closed -$78.8K – 7428
2025
Q2 		$78.8K Buy
+5,000
New +$63.6K ﹤0.01% 5714

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase's CLMT Position: Q1 2026 in Review

JP Morgan Chase increased its Calumet Specialty Products (CLMT) stake by 967% in Q1 2026, buying an estimated $13.6M and bringing the position to 581,137 shares worth $20.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2054.

JP Morgan Chase first reported a position in CLMT in Q2 2013 and has held it in 48 quarters since. The position peaked at $60.8M in Q2 2013. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • JP Morgan Chase held 581,137 shares of Calumet Specialty Products worth $20.4M as of Q1 2026.
  • JP Morgan Chase bought 526,674 Calumet Specialty Products shares in Q1 2026, an estimated $13.6M.
  • Calumet Specialty Products made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2054 holding.
  • JP Morgan Chase first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 48 quarters since.
  • JP Morgan Chase's Calumet Specialty Products position peaked at $60.8M in Q2 2013.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.